Dwayne Jerald Bond v. Commissioner of Social Security

CourtDistrict Court, N.D. Ohio
DecidedJanuary 5, 2026
Docket1:25-cv-00410
StatusUnknown

This text of Dwayne Jerald Bond v. Commissioner of Social Security (Dwayne Jerald Bond v. Commissioner of Social Security) is published on Counsel Stack Legal Research, covering District Court, N.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Dwayne Jerald Bond v. Commissioner of Social Security, (N.D. Ohio 2026).

Opinion

IN THE UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF OHIO EASTERN DIVISION

DWAYNE JERAL BOND, ) CASE NO. 1:25-CV-00410-JRA ) Plaintiffs, ) DISTRICT JUDGE ) JOHN R. ADAMS v. ) ) MAGISTRATE JUDGE COMMISSIONER OF SOCIAL SECURITY, ) CARMEN E. HENDERSON ) Defendant, ) REPORT AND RECOMMENDATION

I. Introduction Plaintiff, Dwayne Bond (“Bond” or “Claimant”), seeks judicial review of the final decision of the Commissioner of Social Security denying his application for Disability Insurance Benefits (“DIB”). This matter is before me pursuant to 42 U.S.C. §§ 405(g), 1383(c)(3), and Local Rule 72.2(b). For the reasons set forth below, it is RECOMMENDED that the Court OVERRULE Claimant’s Statement of Errors and AFFIRM the Commissioner’s decision. II. Procedural History On February 15, 2022, Bond filed applications for DIB and supplemental security income (“SSI”), alleging a disability onset date of January 15, 2015, and claiming he was disabled due to diabetes mellitus type II with neuropathy, degenerative disc disease of the cervical, thoracic, and lumbar spines, and squamous cell carcinoma in situ of the right foot. (ECF No. 8, PageID #: 271– 284, 302, 365–66). On October 21, 2022, the Social Security Administration (“SSA”) approved Bond’s application for SSI.1 (ECF No. 8, PageID #: 154–59). However, Bond’s application for DIB was denied initially and upon reconsideration, and Bond requested a hearing before an administrative law judge (“ALJ”). (ECF No. 8, PageID #: 144–45, 153). On October 19, 2023, an ALJ held a hearing, during which Claimant, represented by counsel, and an impartial vocational

expert testified. (ECF No. 8, PageID #: 100). During the hearing, Bond amended his onset of disability to February 17, 2016, the date on which he attained age 50. (ECF No. 8, PageID #: 98). On February 1, 2024, the ALJ issued a written decision finding Bond was not disabled. (ECF No. 8, PageID #: 73–86). The ALJ’s decision became final on January 7, 2025, when the Appeals Council declined further review. (ECF No. 8, PageID #: 63–68). On March 3, 2025, Bond filed his Complaint to challenge the Commissioner’s final decision. (ECF No. 1.) The parties have completed briefing in this case. (ECF Nos. 10, 12, 13). Bond asserts the following assignment of error: “Whether the ALJ erred when failing to identify substantial evidence supporting the residual functional capacity finding. Whether the ALJ erred when failing to comply with the regulations regarding medical opinion analysis.” (ECF No. 10 at

1). The Court addresses these contentions below. III. Background A. Relevant Hearing Testimony

At the hearing, Claimant appeared with counsel and testified as to his symptoms. (ECF No. 8, PageID #: 92–118). Vocational expert (VE), Jacqueline Kennedy-Merit, testified as to Claimant’s past work and potential to perform light work. (ECF No. 8, PageID #: 109–118). The ALJ noted that the instant case concerned Bond’s DIB claim and as of February 15, 2022, the SSA

1 Because the SSI claim dealt with the period starting February 15, 2022, and the DIB claim dealt with the limited time from February 17, 2016, the alleged onset date, through June 30, 2020, the date last insured, the Court agrees with the ALJ’s assessment that the DIB decision is separate from and does not impact the SSI decision. (ECF No. 8, PageID #: 80). found Bond disabled and issued benefits concerning his Title SSI claim. (ECF No. 8, PageID #: 98). Claimant testified that he stopped taking all his medication for both diabetes and high blood pressure. (ECF No. 8, PageID #: 105). Claimant also testified that he struggled with his vision, he experienced “cracking and bleeding on [his] foot” during the 2016 to 2020 period. (ECF No. 8,

PageID #: 105–107). B. Relevant Medical Evidence

The ALJ also summarized Bond’s health records and symptoms: In 2021, after the date last insured, the claimant was diagnosed with skin cancer affecting his right foot. However, the claimant alleged that he had painful skin problems in his feet since 2016 and required treatment for symptoms during the insured period. The claimant also testified he experienced chronic and severe pain in his neck and back during this period.

After the date last insured, the claimant was diagnosed with transient ischemic attack (TIA), skin cancer involving the right foot, and vision impairment (Exhibits 4F-6F, 2021; 7F, 2022).

Diabetes and Foot impairments Treating physician Rekha Pawar, M.D., recorded the claimant’s diagnosis with Type II diabetes in September 2016, though the record indicates earlier onset (Exhibit 1F/1, 124). At a diabetic podiatry exam in April 2015, the claimant reported numbness, tingling, and burning sensations in his feet and a yearlong history of rash between his last two toes (Exhibit 1F/70) Thomas Schmitt, DPM, reported that the claimant’s skin was supple and intact in the bilateral feet and ankles, he had normal strength and range of motion in both feet, and his protective sensation was intact in all sites on monofilament testing (Exhibit 1F/72). The 3rd and 4th webspaces on the right foot were macerated and erythematous (softened and red), otherwise, all other spaces were clean and dry and no open lesions were noted (Id.). In February 2019, the claimant saw Laura Britt, NP, for a diabetes follow-up (Exhibit 1F/124). The claimant reported he had stopped taking his diabetes medication (glipizide) for the past six months because he had leg pain while on this medication and it resolved when he stopped this medicine; laboratory studies performed at this time showed elevated blood glucose and A1C levels (Exhibit 1F/124, 119). The claimant also reported he stopped taking tramadol for the past six months due to “not wanting to go through process of tox screening” (Exhibit 1F/124). The claimant reported taking ibuprofen as needed for chronic neck and shoulder pain, but denied upper extremity weakness or radiculopathy (Id.). A physical exam revealed steady gait, normal heart and lung sounds, and no edema in the extremities (Id.).

After this, the record does not demonstrate another in-person physical exam until September 2020, about three months after the date last insured (Exhibit 1F/97-99). A diabetic foot exam revealed redness and scaling between two toes in the right foot but otherwise, “pulses intact. No swelling. Monofilament sensation intact.” (Exhibit 1F/99). Ms. Britt also observed steady gait, no edema in the extremities, and normal findings on lung, cardiac, and abdominal exams (Id.).

As noted throughout, diabetic foot exams performed from March 2015 – September 2020 showed focal redness and scaling between the last two toes of the right foot (Exhibit 1F). In April 2021, biopsies of the affected areas did confirm squamous cell carcinoma in situ of the right foot (Exhibit 5F). However, even if an acceptable medical source opined that the claimant’s cancer developed years before it was diagnoses, this alone would not support a finding of disability because no acceptable medical source of record or other treating source reported objective observations of gait limits, weakness, sensation loss, skin lesions, atrophy, or other signs of severe impairment in the claimant’s lower extremities. Regarding diabetes, while an acceptable medical source diagnosed the claimant with diabetes, subsequent physical exams were unremarkable for physical limitations (Exhibit 1F). The claimant reported weight loss in 2020, but did not report vision impairment, altered mental status, or other complications of diabetes during the insured period (Id.).

Alleged Spine Impairments In February 2014, Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bruce Coldiron v. Commissioner of Social Security
391 F. App'x 435 (Sixth Circuit, 2010)
Barbara Combs v. Commissioner of Social Security
459 F.3d 640 (Sixth Circuit, 2006)
Debra Rogers v. Commissioner of Social Security
486 F.3d 234 (Sixth Circuit, 2007)
Fleischer v. Astrue
774 F. Supp. 2d 875 (N.D. Ohio, 2011)
Wilson v. Commissioner of Social Security
280 F. App'x 456 (Sixth Circuit, 2008)
Maryanne Reynolds v. Commissioner of Social Security
424 F. App'x 411 (Sixth Circuit, 2011)
Cynthia Winn v. Comm'r of Social Security
615 F. App'x 315 (Sixth Circuit, 2015)
Crum v. Commissioner of Social Security
660 F. App'x 449 (Sixth Circuit, 2016)
Biestek v. Commissioner of Social Security
880 F.3d 778 (Sixth Circuit, 2017)
Randy Berkshire v. Debra Dahl
928 F.3d 520 (Sixth Circuit, 2019)
Jeffery Emard v. Comm'r of Soc. Sec.
953 F.3d 844 (Sixth Circuit, 2020)

Cite This Page — Counsel Stack

Bluebook (online)
Dwayne Jerald Bond v. Commissioner of Social Security, Counsel Stack Legal Research, https://law.counselstack.com/opinion/dwayne-jerald-bond-v-commissioner-of-social-security-ohnd-2026.